Skip to main content
Erschienen in: Journal of Nuclear Cardiology 4/2019

01.08.2019 | Editorial

Do we need diagnostic strategies enhanced with genetic information for ischemic heart disease?

verfasst von: Pierre-Yves Marie, MD, PhD, Sophie Visvikis-Siest, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Excerpt

Although reliable information on left ventricular (LV) perfusion can be provided at stress with several imaging techniques, myocardial perfusion SPECT imaging (MPI) has the major advantages of being both relatively simple to perform and analyze, with very rare contraindications, and of providing a wide variety of stress and injection protocols, hence allowing this technique to be adapted to each patient and to different indications.1,2 To these advantages, we can add its current high image quality owing to recent technical and methodological advances—i.e., semiconductor detectors, new collimation systems, and/or novel reconstruction software 1,2—thus making MPI more reliable and relevant compared to the past. Moreover, as it can now be performed with a much lower radiation exposure, this evolution is particularly favorable for the growing number of patients referred for repeated ionizing procedures throughout the course of their life.3
Literatur
1.
Zurück zum Zitat Imbert L, Marie PY. CZT cameras: A technological jump for myocardial perfusion SPECT. J Nucl Cardiol. 2016;23:894–6.CrossRefPubMed Imbert L, Marie PY. CZT cameras: A technological jump for myocardial perfusion SPECT. J Nucl Cardiol. 2016;23:894–6.CrossRefPubMed
2.
Zurück zum Zitat Perrin M, Djaballah W, Moulin F, Claudin M, Veran N, Imbert L, et al. Stress-first protocol myocardial perfusion SPECT imaging with semiconductor cameras: High diagnostic performances with significant reduction in patient radiation doses. Eur J Nucl Med Mol Imaging. 2015;42:1004–11.CrossRefPubMed Perrin M, Djaballah W, Moulin F, Claudin M, Veran N, Imbert L, et al. Stress-first protocol myocardial perfusion SPECT imaging with semiconductor cameras: High diagnostic performances with significant reduction in patient radiation doses. Eur J Nucl Med Mol Imaging. 2015;42:1004–11.CrossRefPubMed
3.
Zurück zum Zitat Einstein AJ1, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304(19):2137-2144. Einstein AJ1, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304(19):2137-2144.
4.
Zurück zum Zitat Ronan G, Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol. 2014;21:192–220.CrossRef Ronan G, Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol. 2014;21:192–220.CrossRef
5.
Zurück zum Zitat Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in cardiovascular mortality: Possible causes and implications. Circ Res. 2017;120:366–80.CrossRefPubMedPubMedCentral Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, et al. Decline in cardiovascular mortality: Possible causes and implications. Circ Res. 2017;120:366–80.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904.CrossRefPubMed Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904.CrossRefPubMed
8.
Zurück zum Zitat Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS Data Brief. 2012;103:1–8. Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS Data Brief. 2012;103:1–8.
9.
Zurück zum Zitat Hamrefors V. Common genetic risk factors for coronary artery disease: New opportunities for prevention? Clin Physiol Funct Imaging. 2017;37:243–54.CrossRefPubMed Hamrefors V. Common genetic risk factors for coronary artery disease: New opportunities for prevention? Clin Physiol Funct Imaging. 2017;37:243–54.CrossRefPubMed
10.
11.
Zurück zum Zitat Ndiaye NC, Azimi Nehzad M, El Shamieh S, Stathopoulou MG, Visvikis-Siest S. Cardiovascular diseases and genome-wide association studies. Clin Chim Acta. 2011;412:1697–701.CrossRefPubMed Ndiaye NC, Azimi Nehzad M, El Shamieh S, Stathopoulou MG, Visvikis-Siest S. Cardiovascular diseases and genome-wide association studies. Clin Chim Acta. 2011;412:1697–701.CrossRefPubMed
12.
Zurück zum Zitat Visvikis-Siest S, Stathopoulou MG, Ndiaye NC. Common mutations and polymorphisms predicting adverse cardiovascular events: Current view. Pharmacogenomics. 2012;13:1875–8.CrossRefPubMed Visvikis-Siest S, Stathopoulou MG, Ndiaye NC. Common mutations and polymorphisms predicting adverse cardiovascular events: Current view. Pharmacogenomics. 2012;13:1875–8.CrossRefPubMed
13.
Zurück zum Zitat O’Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011;365:2098–109.CrossRefPubMed O’Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011;365:2098–109.CrossRefPubMed
17.
Zurück zum Zitat Turan N, Katari S, Coutifaris C, Sapienza C. Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics. 2010;5:16–9.CrossRefPubMedPubMedCentral Turan N, Katari S, Coutifaris C, Sapienza C. Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics. 2010;5:16–9.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Zhao Y, Zeng D. Recent development on statistical methods for personalized medicine discovery. Front Med. 2013;7:102–10.CrossRefPubMed Zhao Y, Zeng D. Recent development on statistical methods for personalized medicine discovery. Front Med. 2013;7:102–10.CrossRefPubMed
20.
Zurück zum Zitat Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: Current state and future directions. Heart Fail Rev. 2017;22:441–53.CrossRefPubMed Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: Current state and future directions. Heart Fail Rev. 2017;22:441–53.CrossRefPubMed
Metadaten
Titel
Do we need diagnostic strategies enhanced with genetic information for ischemic heart disease?
verfasst von
Pierre-Yves Marie, MD, PhD
Sophie Visvikis-Siest, PhD
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2019
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1240-9

Weitere Artikel der Ausgabe 4/2019

Journal of Nuclear Cardiology 4/2019 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.